The Oncosearch | Oncotarget

GRP78 enhances the glutamine metabolism to support cell survival from glucose deficiency by modulating the Î²-catenin signaling Research Paper

Zongwei Li, Yingying Wang, Haili Wu, Lichao Zhang, Peng Yang, Zhuoyu Li

Published Jun 14, 2014 · Vol. 5, No. 14 · pp. 5369-5380

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma Clinical Research Papers

Eva Giesen, Lucia B. Jilaveanu, Fabio Parisi, Yuval Kluger, Robert L. Camp, Harriet M. Kluger

Published Jun 13, 2014 · Vol. 5, No. 14 · pp. 5209-5217

Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/Î²-catenin signalling in pancreatic adenocarcinoma Research Paper

Mina Maftouh, Ana I. Belo, Amir Avan, Niccola Funel, Godefridus J. Peters, Elisa Giovannetti, Irma van Die

Published Jun 13, 2014 · Vol. 5, No. 14 · pp. 5335-5349

Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration Research Paper

Christina A. von Roemeling, Laura A. Marlow, Derek C. Radisky, Austin Rohl, Hege E. Larsen, Johnny Wei, Heather Sasinowska, Heng Zhu, Richard Drake, Maciek Sasinowski, Han W. Tun, John A. Copland

Published Jun 12, 2014 · Vol. 5, No. 14 · pp. 5320-5334

The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease Research Paper

John T. Patton, Mark E. Lustberg, Gerard Lozanski, Sabrina L. Garman, William H. Towns, Callie M. Drohan, Amy Lehman, Xiaoli Zhang, Brad Bolon, Li Pan, A. Douglas Kinghorn, Michael R. Grever, David M. Lucas, Robert A. Baiocchi

Published Jun 12, 2014 · Vol. 6, No. 5 · pp. 2693-2708

RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth Research Paper

Kathleen A. Wilson-Edell, Amanuel Kehasse, Gary K. Scott, Christina Yau, Daniel E. Rothschild, Birgit Schilling, Bianca S. Gabriel, Mariya A. Yevtushenko, Ingrid M. Hanson, Jason M. Held, Bradford W. Gibson, Christopher C. Benz

Published Jun 12, 2014 · Vol. 5, No. 13 · pp. 5165-5176

Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRÎ±-expressing cells Research Paper

Yingying Shen, Xiaomei Ren, Ke Ding, Zhang Zhang, Deping Wang, Jingxuan Pan

Published Jun 11, 2014 · Vol. 5, No. 21 · pp. 10407-10420

Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells Research Paper

Kathleen A. Bridges, Carlo Toniatti, Carolyn A. Buser, Huifeng Liu, Thomas A. Buchholz, Raymond E. Meyn

Published Jun 9, 2014 · Vol. 5, No. 13 · pp. 5076-5086

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia Research Paper

Jochen J. Frietsch, Carolin Kastner, Thomas G. P. Grunewald, Hardy Schweigel, Peter Nollau, Janine Ziermann, Joachim H. Clement, Paul La RosÃ©e, Andreas Hochhaus, Elke Butt

Published Jun 7, 2014 · Vol. 5, No. 14 · pp. 5257-5271

Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma Research Paper

Scott A. Ezell, Michele Mayo, Teeru Bihani, Suprawee Tepsuporn, Suping Wang, Melissa Passino, Shaun E. Grosskurth, Mike Collins, Julie Parmentier, Corinne Reimer, Kate F. Byth

Published Jun 7, 2014 · Vol. 5, No. 13 · pp. 4990-5001

Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts Research Paper

Mi Sun Park, Seung Myung Dong, Boh-Ram Kim, Seung Hee Seo, Sokbom Kang, Eun-Ju Lee, Seung-Hoon Lee, Seung Bae Rho

Published Jun 6, 2014 · Vol. 5, No. 13 · pp. 4929-4934

The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1Î± expression Research Paper

Mi Sun Park, Boh-Ram Kim, Seung Myung Dong, Seung-Hoon Lee, Dae-Yong Kim, Seung Bae Rho

Published Jun 6, 2014 · Vol. 5, No. 13 · pp. 4935-4944

miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT Research Paper

Nianli Liu, Chaohui Zuo, Xiaohong Wang, Tianran Chen, Darong Yang, Jing Wang, Haizhen Zhu

Published Jun 6, 2014 · Vol. 5, No. 13 · pp. 4959-4971

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells Research Paper

Bruna Corominas-Faja, Elisabet CuyÃ s, Juan Gumuzio, Joaquim Bosch-Barrera, Olatz Leis, Ãngel G. Martin, Javier A. Menendez

Published Jun 5, 2014 · Vol. 5, No. 18 · pp. 8306-8316

RFX1â€“dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells Research Paper

Jung-Chen Su, Ping-Hui Tseng, Cheng-Yi Hsu, Wei-Tien Tai, Jui-Wen Huang, Ching-Huai Ko, Mai-Wei Lin, Chun-Yu Liu, Kuen-Feng Chen, Chung-Wai Shiau

Published Jun 3, 2014 · Vol. 5, No. 13 · pp. 4909-4919

A highly recurrent RPS27 5â€™UTR mutation in melanoma Priority Research Paper

Ken Dutton-Regester, Jared J. Gartner, Rafi Emmanuel, Nouar Qutob, Michael A. Davies, Jeffrey E. Gershenwald, William Robinson, Steven Robinson, Steven A. Rosenberg, Richard A. Scolyer, Graham J. Mann, John F. Thompson, Nicholas K. Hayward, Yardena Samuels

Published Jun 1, 2014 · Vol. 5, No. 10 · pp. 2912-2917

Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells Research Paper

Wenwen Chien, Ling-Wen Ding, Qiao-Yang Sun, Lucia A. Torres-Fernandez, Siew Zhuan Tan, Jinfen Xiao, Su Lin Lim, Manoj Garg, Kian Leong Lee, Shojiro Kitajima, Sumiko Takao, Wei Zhong Leong, Haibo Sun, Itay Tokatly, Lorenz Poellinger, Sigal Gery, Phillip H. Koeffler

Published Jun 1, 2014 · Vol. 5, No. 13 · pp. 4881-4894

Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients Research Paper

Er-Chieh Cho, Mei-Ling Kuo, Xiyong Liu, Lixin Yang, Yi-Chen Hsieh, Jinghan Wang, Yawen Cheng, Yun Yen

Published May 31, 2014 · Vol. 5, No. 13 · pp. 4834-4844

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing Research Paper

Filip Janku, Ahmed O. Kaseb, Apostolia M. Tsimberidou, Robert A. Wolff, Razelle Kurzrock

Published May 30, 2014 · Vol. 5, No. 10 · pp. 3012-3022

Keywords: hepatocellular carcinoma, PI3K, AKT, mTOR, next generation sequencing

20(S)-Ginsenoside Rg₃ is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin Research Paper

Dong-Gun Kim, Kyung Hee Jung, Da-Gyum Lee, Jung-Ho Yoon, Kyeong Sook Choi, Sung Won Kwon, Han-Ming Shen, Michael J. Morgan, Soon-Sun Hong, You-Sun Kim

Published May 28, 2014 · Vol. 5, No. 12 · pp. 4438-4451

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

GRP78 enhances the glutamine metabolism to support cell survival from glucose deficiency by modulating the Î²-catenin signaling Research Paper

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma Clinical Research Papers

Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/Î²-catenin signalling in pancreatic adenocarcinoma Research Paper

Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration Research Paper

The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease Research Paper

RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth Research Paper

Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRÎ±-expressing cells Research Paper

Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells Research Paper

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia Research Paper

Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma Research Paper

Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts Research Paper

The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1Î± expression Research Paper

miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT Research Paper

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells Research Paper

RFX1â€“dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells Research Paper

A highly recurrent RPS27 5â€™UTR mutation in melanoma Priority Research Paper

Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells Research Paper

Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients Research Paper

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing Research Paper

20(S)-Ginsenoside Rg₃ is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

GRP78 enhances the glutamine metabolism to support cell survival from glucose deficiency by modulating the Î²-catenin signaling Research Paper

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma Clinical Research Papers

Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/Î²-catenin signalling in pancreatic adenocarcinoma Research Paper

Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration Research Paper

The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease Research Paper

RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth Research Paper

Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRÎ±-expressing cells Research Paper

Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells Research Paper

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia Research Paper

Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma Research Paper

Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts Research Paper

The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1Î± expression Research Paper

miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT Research Paper

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells Research Paper

RFX1â€“dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells Research Paper

A highly recurrent RPS27 5â€™UTR mutation in melanoma Priority Research Paper

Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells Research Paper

Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients Research Paper

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing Research Paper

20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin Research Paper

20(S)-Ginsenoside Rg₃ is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin Research Paper